FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy

Our aim was to analyse whether biomarkers extracted from baseline (18)F-FDG PET before anti-PD1 treatment contribute to prognostic survival information for early risk stratification in metastatic melanoma. Fifty-six patients, without prior systemic treatment, BRAF wild type, explored using (18)F-FDG...

Descripción completa

Detalles Bibliográficos
Autores principales: Flaus, A., Habouzit, V., De Leiris, N., Vuillez, J. P., Leccia, M. T., Perrot, J. L., Prevot, N., Cachin, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458464/
https://www.ncbi.nlm.nih.gov/pubmed/34552135
http://dx.doi.org/10.1038/s41598-021-98310-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458464/
https://www.ncbi.nlm.nih.gov/pubmed/34552135
http://dx.doi.org/10.1038/s41598-021-98310-3

Ejemplares similares